Chronic Spontaneous Urticaria. Other urticaria (Urticaria: chronic, recurrent periodic)
Conditions
Interventions
Patients will be divided into idiopathic and autoimmune forms of urticaria after the autologous plasma skin test. After consent to participate in the study, 5cc of brachial vein blood will be sampled
Treatment - Other
Sponsors
Vice-chancellor for Research of Bushehr University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria are urticaria for more than 2 months; Age over than 15 year old; Consent to participate in the study; Negative Prick skin test for common inhalation and food allergens and normal findings in Lab data such as CBC (Complete Blood Count), ANA (Antinuclear antibody), ESR (Erythrocyte Sedimentation Rate), LFT (Liver Function Test), U/A (Urine Analysis) and S/E (Stool Exam). Exclusion criteria are Pregnancy; Physical urticaria; Use of corticosteroid and immunosuppressive agents during the last 6 weeks; Use of drugs other than antihistamine and other systemic diseases.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Qualitative clinical symptoms of urticaria. Timepoint: Before the treatment, every week during the treatment and one week after the treatment. Method of measurement: Changes in DLQI (Dermatology Life Quality Index). | — |
Secondary
| Measure | Time frame |
|---|---|
| Quantitative clinical symptoms of urticaria. Timepoint: Before the treatment, every week during the treatment for 10 weeks and one week after the treatment. Method of measurement: Changes in TSS (Total Symptoms Score) index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfshin Shirkani
Faculty of Medicine. Bushehr University of Medical Sciences.
Outcome results
None listed